|
Q2 FY2026
As of Jun 27, 2026
|
Q1 FY2026
As of Mar 28, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 27, 2025
|
Q2 FY2025
As of Jun 28, 2025
|
Q1 FY2025
As of Mar 29, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 28, 2024
|
Q2 FY2024
As of Jun 29, 2024
|
Q1 FY2024
As of Mar 30, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jul 1, 2023
|
Q1 FY2023
As of Apr 1, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 24, 2022
|
Q2 FY2022
As of Jun 25, 2022
|
Q1 FY2022
As of Mar 26, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 25, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable, net (Note 4) | ||||||||||||||||||||
| Inventory (Note 5) | ||||||||||||||||||||
| Income tax receivable (Note 21) | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment (net of accumulated depreciation of $2,086,605 and $1,994,671, respectively) | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities, Redeemable Noncontrolling Interest and Stockholders’ Equity | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued and other current liabilities (Note 6) | ||||||||||||||||||||
| Debt due within one year (Note 7) | ||||||||||||||||||||
| Current environmental liabilities (Note 8) | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt (Note 7) | ||||||||||||||||||||
| Non-current environmental liabilities (Note 8) | ||||||||||||||||||||
| Pension and other postretirement benefits (Note 14) | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Redeemable noncontrolling interest (Note 10) | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common stock: 140,000,000 shares authorized at $0.01 par value, 67,634,382 and 67,005,593 issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss (Note 11) | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities, redeemable noncontrolling interest and stockholders’ equity | ||||||||||||||||||||
Loading...
